Fogorvosi szemle, 2007 (100. évfolyam, 1-6. szám)

2007-10-01 / 5. szám

FOGORVOSI SZEMLE

100. évf. 5. sz. 2007.

257

19. Hashibe M, Jacob BJ, Thomas G: Socioeconomic status, lifestyle factors and oral premalignant lesions. Oral Oncol 2003; 39: 664- 671.

20. Hussain SP, Hofseth LJ, Harris CC: Nitric oxide in cancer and chemoprevention. Free Radie Biol Med 2003; 34: 955-968.

21. Inoue M, Iwasaki M, Otani T, Sasazuki S, Noda M, Tsugane S: Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 2006; 166: 1871-1877.

22. Iype EM, Pandey M, Mathew A, Thomas G, Sebastian P, Naïr MK: Oral cancer among patients under the age of 35 years. J Postgrad Med 2001; 47: 171-176.

23. Jee SH, Ohrr H, Sull JW, Yun JE, Ji M, Samet JM: Fasting serum glucose level and cancer risk in Korean men and women. JAMA 2005; 293: 194-202.

24. Johnson NW: Etiology and risk factors for oral cancer, with special reference to tobacco and alcohol use. Hungarian Oncol 2001 ; 45: 115-122.

25. Kinane DF, Chestnutt IG: Smoking and periodontal disease. Critical Reviews in Oral Biology & Medicine 2000; 11: 356-365.

26. Krolls SO, Hoffmann S: Squamous cell carcinoma of the oral soft tissues: a statistical analysis of 14 253 cases by age, sex, and race of patients. JADA 1976; 92: 571-574.

27. Kunkel M, Reichert TE, Benz P: Overexpression of Glut-1 and increased metabolism in tumors are associated with poor prognosis in patients with oral squamous cell carcinoma. Cancer 2003; 97: 1015-1020.

28. Kuriki K, Hírőse K, Tajima K: Diabetes and cancer risk for all and specific sites among Japanese men and women. EurJ Cancer Prev 2007;16:83-89.

29. Lindblad P, Chow WH, Chan J: The role of diabetes mellitus in the etiology of renal cell cancer. Diabetologica 1999; 42: 107-112.

30. Llewellyn CD, Johnson NW, Warnakulasuriya KA: Risk factors for oral cancer in newly diagnosed patients aged 45 years and younger: a case-control study in Southern England. J Oral Pathol Med2004; 33: 525-532.

31. Lorenzi M: Glucose toxicity in the vascular complications of diabetes: The cellular perspective. Diabetes Metab Rev 1992; 8: 85-103.

32. Mahboubi E: The epidemiology of oral cavity, pharyngeal and esophageal cancer outside of North America and Western Europe. Cancer 1977; 40: 1879-1886.

33. Manoucher-Pour M, Spagnuolo PJ, Rodman HM, Bissada NF: Comparison of neutrophil chemotactic response in diabetic patients with mild and severe periodontal disease. J Periodontol 1981; 52: 410-415.

34. McCall JL,Tuckey JA, Parry BRL: Serum tumor necrosis factor alfa and insulin resistance in gastrointestinal cancer. BrJ Surg 1992; 79: 1361-1365.

35. Mealey BL, Moritz AJ: Hormonal influences: effects of diabetes mellitus and endogenous female sex steroid hormones on the periodontium. Periodontology 2000. 2003; 32: 59-81.

36. Meyerhardt JA, Catalano PJ, Haller DG, Mayer RJ, Macdonald JS, Benson AB, Fuchs CS: Inpact of diabetes mellitus on outcomes in patients with colon cancer. J Clin Oncol2003; 21: 433-440.

37. Mogyorósi A, Ziyadeh FN: GLUT1 andTGF-beta: the link between hyperqlycaemia and diabetic nephropathy. Nephrol Dial Transplant 1999; 14: 2827-2831.

38. Monnier VM, Glomb M, Elgawish A, Sell DR: The mechanism of collagen cross-linking in diabetes. A puzzle nearing resolution. Diabetes 1996; 45: (Suppl 3): s67-s72.

39. Munkholm P: The incidence and prevalence of colorectal cancer in inflammatory bowel disease. Aliment Pharmacol Ther2003; 2: 1-5.

40. Nagel JM, Goke B: Colorectal carcinoma in patients with type-2 diabetes mellitus. Z Gastroenterol 2006; 44: 1153-1165.

41. Neville BW, Day TA: Oral cancer and precancerosus lesions. CA Cancer J Clin 2002; 52: 195-201.

42. Oliver RJ, Woodwards RT, Sloan P: Prognostic value of facilitative glucose transporter Glut-1 in oral squamous cell carcinomas treated by surgical resection; results of EORTC Transplantational Research Fund studies. EurJ Cancer 2004; 40: 503-508.

43. Park SM, Lim MK, Shin SA, Yun YH: Impact of prediagnosis smoking, alcohol, obesity, and insulin resistance on survival in male cancer patients: National Health Insurance Corporation Study. J Clin Oncol 2006; 24: 5017-5024.

44. Ponte E, Tabaj D, Maglione M, Melato M: Diabetes mellitus and oral disease. Acta Diabetol 2001 ; 38: 57-62.

45. Rapp K, Schroeder J, Klenk J, Ulmer H, Concin H, Diem G, Oberaigner W, Weiland SK: Fasting blood glucose and cancer risk in a cohort of more than 140,000 adults in Austria. Diabetologia 2006; 49: 945-952.

46. Reaven GM: Banting lecture 1988: Role of insulin resistance in human disease. Diabetes 1988; 37: 1595-1607.

47. Rich AM, Radden BG: Squamous cell carcinoma of the oral mucosa: a review of 244 cases in Australia. J Oral Pathol 1984; 13: 459-471.

48. Richardson LC, Pollack LA: Therapy insight: Influence of type 2 diabetes on the development, treatment and outcomes of cancer. Nat Clin Pract Oncol 2005; 2: 48-53.

49. Riu L, Aguirre V, Kim JK: lnsulin/IGF-1 and TNF-alpha stimulates phosphorilation of IRS-1 at inhibitory Ser 307 via distinct pathways. JClin Invest 2001; 107: 181-189.

50. Rosenquist K, Wennerberg J, Schildt EB: Oral status, oral infections, and some lifestyle factors as risk factors for oral and oropharyngeal squamous cell carcinoma: A population-based case control study in southern Sweden. Acta Otolaryngol 2005; 125: 1327-1336.

51. Salahudeen AK, Kanji V, Reckelhoff JF: Pathogenesis of diabetic nephropathy: A radical approach. Nephrol Dial Transplant 1997; 12: 664.

52. Schmidt AM, Hori O, Cao R: RAGE-a novel cellular receptor for advanced glycation end products. Diabetes 1996; 45: 77-81.

53. Schneider JG, Tompkins C, Blumenthal RS, Mora S: The metabolic syndrome in women. Cardiol Rev2006; 14: 286-291.

54. Sreebny LM, Yu A, Green A, Valdini A: Xerostomia in diabetes mellitus. Diabetes Care 1992; 15: 900-904.

55. Sturmer T, Buring JE, Lee IM, Gaziano JM, Glynn RJ: Metabolic abnormalities and risk for colorectal cancer in the physicians’ health study. Cancer Epidemiol Biomarkers Prev 2006; 15: 2391-2397.

56. Suba Zs, Ujpál M: Correlations of insulin resistance and tumors. Hungarian Oncology 2006; 50: 127-135.

57. Suba Zs, Barabás J, Szabó Gy, Takács D, Ujpál M: Increased prevalence of diabetes and obesity in patients with salivary gland tumors. Diabetes Care 2005; 16: 228-229.

58. Suba Zs: Gender-related hormonal risk factors for oral cancer. Pathol Oncol Res (in press 2007).

59. Tsuji S, Kawai N, Tsuji M, Kawano S, Hori M: Review article: inflammation-related promotion of gastrointestinal carcinogenesis: a perigenetic pathway. Aliment Pharmacol Ther 2003; 1: 82-89.

60. Ujpál M, Matos O, BIbok Gy, Somogyi A, Szabó Gy, Suba Zs: Diabetes and Oral tumors in Hungary: Epidemiological correlations. Diabetes Care 2004; 27: 770-774.

61. Ujpál M, Barabás J, Kovalszky I, Szabó GY, Németh ZS, Gábris K, Suba ZS: A preliminary comparative study of the prognostic implications of type 2 diabetes mellitus for patients with primary gingival carcinoma treated with surgery and radiation therapy. J Oral Maxillofac Surg 2007; 65: 452-456.

62. Vlassara H, Brownlee M, Monogue K, Dinarello CA, Pasagian A: Cachetin/TNF and IL-1 induced by glucose-modified proteins: role in normal tissue remodelling. Science 1988; 240: 1546-1548.

63. Werner H, Katz J: The emerging role of the insulin-like growth factors in oral biology. J Dental Res 2004; 83: 832-836.

64. Yamamoto E, Miyakawa A, Kohama G: Mode of invasion and lymph node metastases in squamous cell carcinoma of the oral cavity. Head Neck Surg 1994; 6: 938-943.